Antimetastatic effect of CpG DNA mediated by type I IFN

Cancer Research

Volumn 61, Issue 14, 2001, Pages 5523-5528

  Hafner, Michael ^a   Zawatzky, Rainer ^b   Hirtreiter, Christian ^a   Buurman, Wim A ^c   Echtenacher, Bernd ^a   Hehlgans, Thomas ^a   Männel, Daniela N ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Tumor Immunology Program   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; OLIGODEOXYNUCLEOTIDE; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOTOXICITY; DNA FLANKING REGION; DNA SEQUENCE; IMMUNE RESPONSE; METASTASIS; METASTASIS INHIBITION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CPG ISLANDS; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; DNA; DNA METHYLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INTERFERON TYPE I; INTERFERON-ALPHA; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED STRAINS; MICE, SCID; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; TUMOR CELLS, CULTURED;

EID: 0035878848     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Subversion of the immune system by pathogens
2. Immune activation by bacterial DNA: A new genetic code
3. Lipofection of synthetic oligodeoxyribonucleotide having a palindromic sequence of AACGTT to murine splenocytes enhances interferon production and natural killer activity
4. CpG motifs in bacterial DNA trigger direct B-cell activation
5. IFN-γ promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides
6. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ
7. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α
8. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA
9. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants
10. A toll-like receptor recognizes bacterial DNA
11. Macrophages sense pathogens via DNA motifs: Induction of tumor necrosis factor-α-mediated shock
12. Macrophages ingest and are activated by bacterial DNA
13. Immunostimulatory DNA sequence-dependent production of potentially harmful or useful cytokines
14. IFN-γ primes macrophage responses to bacterial DNA
15. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
16. DNA activates human immune cells through a CpG sequence-dependent manner
17. CpG DNA and LPS induce distinct patterns of activation in human monocytes
18. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
19. Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18, and IFN-γ production in cells from allergic individuals and inhibit IgE synthesis in vitro
20. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth
21. Oligonucleotide sequences required for natural killer cell activation
22. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity
23. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells
24. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12
25. Contribution of CpG motifs to the immunogenicity of DNA vaccines
26. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
27. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria
28. Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response
29. Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major
30. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-γ-dependent mechanisms
31. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis
32. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides
33. DNA-based immunization for asthma
34. Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysaccharides
35. Bacterial DNA causes septic shock
36. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis
37. Cancer cell invasion and metastasis
38. Functional role of type I and type II interferons in antiviral defense
39. MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity
40. Interleukin-12 activates NK cells for IFN-γ-dependent and NKT cells for IFN-γ-independent antimetastatic activity
41. Scattered micrometastases visualized at the single-cell level: Detection and re-isolation of lacZ-labeled metastasized lymphoma cells
42. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor β chain monoclonal antibody in mice
43. Ischemia/reperfusion-induced IFN-γ up-regulation: Involvement of IL-12 and IL-18
44. Monoclonal antibody to murine γ interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities
45. pEF-BOS, a powerful mammalian expression vector
46. Details of an isolation method for hepatic lymphocytes in mice
47. Interferon-induced expression of If-1h and If-1l alleles in Newcastle disease virus-infected mouse macrophages is associated with specific differences in viral gene transcription
48. Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons
49. Requirement for Vαl4 NKT cells in IL-12-mediated rejection of tumors
50. Antimetastatic effect of NK1+ T cells on experimental haematogenous tumour metastases in the liver and lungs of mice
51. Major histocompatibility complex class I related molecules control the development of CD4+8- and CD4-8- subsets of natural killer 1.1+ T cell receptor-α/β cells in the liver of mice
52. Class I dependence of the development of CD4+ CD8- NK1.1+ thymocytes
53. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity
54. Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors
55. Antitumor activity of synthetic oligonucleotides with sequences from cDNA encoding proteins of Mycobacterium bovis BCG
56. Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma
57. Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides
58. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation
59. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice
60. Pharmacokinetics of antisense oligonucleotides
61. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides
62. Interferon: A major regulator of natural killer cell-mediated cytotoxicity
63. Stimulation of NK cell cytotoxic potential of normal donors by two species of recombinant α interferon
64. Interferon-α activates cytotoxic function but inhibits interleukin-2-mediated proliferation and tumor necrosis factor-α secretion by immature human natural killer cells
65. Interferon-α (IFN-α) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway
66. Induction of fas ligand-mediated apoptosis by interferon-α
67. Type I interferon-mediated stimulation of T cells by CpG DNA